Immune checkpoint inhibitors (ICI) in advanced upper tract and lower tract urothelial carcinoma (UC): A comparison of outcomes.
Year: 2021
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Stepan M. Esagian, Ali Raza Khaki, Lucia Carril-Ajuria, Joseph J. Park, Mehmet Asim Bilen, Tyler Francis Stewart, Victor Sacristan Santos, Jayanshu Jain, Rafael Morales-Barrera, Michael Edward Devitt, Christopher J. Hoimes, Evan Shreck, Abhishek Tripathi, Roubini Zakopoulou, Alejo Rodriguez-Vida, Alexandra Drakaki, Vivek Kumar, Pavlos Msaouel, Vadim S Koshkin, Petros Grivas
Institutions: Democritus University of Thrace, University of Washington, Fred Hutch Cancer Center, Hospital Universitario 12 De Octubre, University of Michigan, Winship Cancer Institute, University of California San Diego, University of Utah, University of Iowa Health Care, Universitat Autònoma de Barcelona, Vall d'Hebron Hospital Universitari, Vall d'Hebron Institute of Oncology, University of Virginia Medical Center, University of Virginia, Duke University, Duke Medical Center, Montefiore Medical Center, OU Health Stephenson Cancer Center, University of Oklahoma Health Sciences Center, National and Kapodistrian University of Athens, Alexandra Hospital, Hospital del Mar Research Institute, University of California, Los Angeles, Brigham and Women's Hospital, Harvard University, The University of Texas MD Anderson Cancer Center, University of California, San Francisco, University of California San Francisco Medical Center, Seattle Cancer Care Alliance
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3133503852